Related Experiment Video
Updated: Dec 29, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Myocardial Function Maturation in Very-Low-Birth-Weight Infants and Development of Bronchopulmonary Dysplasia
Paula Méndez-Abad1,2, Pamela Zafra-Rodríguez1,2, Simón Lubián-López1,2
1Department of Neonatology, Puerta del Mar University Hospital, Cádiz, Spain.
Insights
Myocardial function in premature infants evolves differently in those who develop bronchopulmonary dysplasia (BPD). Echocardiographic measures and NTproBNP levels can identify infants at higher risk for BPD.
Area of Science:
- Neonatal Cardiology
- Pediatric Pulmonology
- Biomarker Discovery
Background:
- Myocardial function development in very-low-birth-weight infants (VLBWIs) is crucial for postnatal adaptation.
- Understanding temporal changes in cardiac function related to bronchopulmonary dysplasia (BPD) is limited.
Purpose of the Study:
- To investigate the temporal evolution of myocardial function in VLBWIs.
- To identify echocardiographic and biochemical markers associated with BPD development.
Main Methods:
- Prospective cohort study of VLBWIs.
- Serial echocardiography (TAPSE, TDI) and NTproBNP measurements.
- Comparison of cardiac parameters between non-BPD and BPD groups.
Main Results:
- Cardiac function parameters (TAPSE, TDI) improved over time but were influenced by gestational age (GA) and postmenstrual age (PMA).
- Temporal evolution of cardiac function differed significantly between infants who developed BPD and those who did not.
- NTproBNP levels and echocardiographic parameters at 14 days were associated with BPD development.
Conclusions:
- Gestational age and postmenstrual age impact myocardial function in VLBWIs.
- Cardiac function's temporal evolution differs in infants who develop BPD.
- Combined biomarkers can predict BPD risk in VLBWIs.
Abstract:
Background: Myocardial function in very-low-birth-weight infants (VLBWIs) develops during early postnatal life, but different patterns of temporal evolution that might be related to the development of bronchopulmonary dysplasia (BPD) are not completely understood. Methods: A prospective cohort study including VLBWIs admitted to our NICU from January 2015 to 2017 was conducted. Plasma N-terminal pro B type natriuretic peptide (NTproBNP) levels were measured, and echocardiograms were performed at 24 and 72 h of life and weekly thereafter until 36 weeks of postmenstrual age (PMA). We measured the tricuspid annular plane systolic excursion (TAPSE) by M-mode; the lateral tricuspid E', A', and S' waves; and the myocardial performance index (MPI) by tissue doppler imaging (TDI). The subjects were divided into non-BPD and BPD groups. Results: We included 101 VLBWIs. The TAPSE and E', A', and S' waves increased while MPI-TDI decreased over time. Birth gestational age (GA) and postnatal PMA impacted these parameters, which evolved differently in those who developed BPD compared to those in the non-BPD group. The NTproBNP levels at 14 days of life and different echocardiographic parameters were associated with the development of BPD in different multivariate models. Conclusion: TAPSE and TDI values depend on GA and PMA and follow a different temporal evolution that is related to the later development of BPD. Combined biochemical and echocardiographic biomarkers can help identify which VLBWIs are at higher risk of developing BDP.
More Related Videos
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Mitral Valve Prolapse I: Introduction
Cardiomyopathy VI: Nursing Management

